Compass Pathways (CMPS)

• Market cap: $1.22B
• 1 day: -0.55%
• 5 days: -6.24%
• 1 month: 60.32%
• 3 months: 36.31%
• 6 months: 51.43%
• Year to date: 37.56%
• 1 year: 119.76%
• 5 years: -75.11%
• 10 years: -68.93%
• Sector: Healthcare
• Industry: Medical Care Facilities

About: Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.

Employees: 156